C3 and Stroke: The MPC-n(IVIg)-treated group showed decreased levels of C3b compared to the free IVIg-treated group, indicating that administration of low-dosage MPC-n(IVIg) (100 mg/kg) was effective in reducing stroke-induced C3b during early ischemic-reperfusion.